medicines that are substrates in the CYP3A enzyme as they may come to be significantly less successful throughout procedure with JOURNAVX. Your healthcare company may have to regulate the dose of one's medication when beginning or stopping JOURNAVXThis structural difference has led researchers to examine option pathways for its outcomes. The molecu